@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix go: . @prefix Protein: . @prefix sfam: . @prefix geneProductOf: . @prefix hasAgent: . @prefix sdis: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix do: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasAgent: sub:_2; a go:0005525 . sub:_2 geneProductOf: sfam:RAS%20Family; a Protein: . sub:_3 occursIn: do:1936, obo:CL_0000115, obo:UBERON_0004535, species:10090; rdf:object sdis:Atherosclerotic%20lesion; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "gtp(p(SFAM:\"RAS Family\")) -> path(SDIS:\"Atherosclerotic lesion\")" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_5; pav:version "20131211" . sub:_4 prov:value "Consistent with these findings, inhibition of Ras activity has been demonstrated to suppress the release of proinflammatory molecules, thereby reducing lesion formation in apoE-deficient mice.125"; prov:wasQuotedFrom pubmed:17204661 . sub:_5 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:17204661; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:07.876+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }